Mary Catherine Tanner is an investment banker, with more than 25 years of experience on Wall Street. She specializes in the areas of biotechnology, pharmaceuticals, and health care services. Her expertise includes ethical pharmaceuticals and green technology. Fluent in both English and French, she specializes in cross-border transactions between large and small companies, corporate partnering and minority investments.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| |
rdfs:comment
| - Mary Catherine Tanner is an investment banker, with more than 25 years of experience on Wall Street. She specializes in the areas of biotechnology, pharmaceuticals, and health care services. Her expertise includes ethical pharmaceuticals and green technology. Fluent in both English and French, she specializes in cross-border transactions between large and small companies, corporate partnering and minority investments. (en)
|
foaf:name
| |
name
| |
foaf:depiction
| |
birth date
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
sameAs
| |
work institution
| - EVOLUTION Life Science Partners, Peter J. Solomon Company, Lehman Brothers (en)
|
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
alma mater
| |
birth date
| |
field
| |
spouse
| |
has abstract
| - Mary Catherine Tanner is an investment banker, with more than 25 years of experience on Wall Street. She specializes in the areas of biotechnology, pharmaceuticals, and health care services. Her expertise includes ethical pharmaceuticals and green technology. Fluent in both English and French, she specializes in cross-border transactions between large and small companies, corporate partnering and minority investments. As of 2014, Tanner was Senior Managing Director of EVOLUTION Life Science Partners (ELSP), and a co-founder and chair of Life Science Partners LLP.Previously she served as Senior Managing Director of Lehman Brothers, Bear Stearns, and the Peter J. Solomon Company. Tanner was the first woman to become a partner at Lehman Brothers.She is credited with directing over 130 IPOs for life sciences organizations, and over 500 mergers and acquisitions. (en)
|
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
academic discipline
| |
alma mater
| |
spouse
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is Wikipage redirect
of | |
is spouse
of | |
is spouse
of | |
is foaf:primaryTopic
of | |